Paper53111
35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid.
Lazarus JH and 3 others. Clin Endocrinol (Oxf), 1975. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. 35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid. Papers, record 53111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/53111
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antithyroid Agents | Major topic |
| Iodine | Major topic |
| Thyroid Gland | Major topic |
| Carbimazole | |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Male | |
| Methimazole | |
| Propylthiouracil | |
| Thyroid Diseases | |
| Time Factors |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28973696 | Neurodevelopment and Thyroid Hormone Synthesis Inhibition in the Rat: Quantitative Understanding Within the Adverse Outcome Pathway Framework. | Toxicol Sci | 2017 | https://conductscience.org/library/papers/28973696 | PubMed |
| 9486413 | Phenothiazine-induced increase in thyroid autoantigens and costimulatory molecules on thyroid cells: a pathophysiological mechanism for drug-induced autoimmunity? | Clin Exp Immunol | 1998 | https://conductscience.org/library/papers/9486413 | PubMed |
| 7376643 | Single daily dose methimazole treatment of hyperthyroidism. | West J Med | 1980 | https://conductscience.org/library/papers/7376643 | PubMed |
| 7332734 | Correlation between antithyroid effect and serum concentrations of propylthiouracil in patients with hyperthyroidism. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7332734 | PubMed |
| 6893563 | Carbimazole and autoantibody synthesis in Hashimoto's thyroiditis. | Br Med J | 1980 | https://conductscience.org/library/papers/6893563 | PubMed |
| 6282385 | Specificity of the immunosuppressive action of carbimazole in Graves's disease. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6282385 | PubMed |
| 6180218 | Pharmacokinetics of antithyroid drugs. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/6180218 | PubMed |
| 6172233 | Clinical pharmacokinetics of antithyroid drugs. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/6172233 | PubMed |
| 6156842 | Comparative In Vitro Effects and In Vivo Kinetics of Antithyroid Drugs. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6156842 | PubMed |
| 3305681 | Initial treatment of thyrotoxic Graves' disease with methimazole: a randomized trial comparing different dosages. | J Endocrinol Invest | 1987 | https://conductscience.org/library/papers/3305681 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/53111
GET https://conductscience.org/api/papers/v1/53111/authors